A mother presented her 1-month old term infant with a slowly progressive subcutaneous 1.2 by 1.2 cm swelling on the left upper arm (Fig. 1a) . On the same site, 0.1 mL Bacille Calmette-Guérin (BCG) vaccine had been provided intradermally on the day of birth. Manufactured by Queen Saovabha Memorial Institute, Thai Red Cross Society, Bangkok, Thailand (Lot No. FB00817), 1 mL contains about 2 million viable bacteria of the live attenuated Mycobacterium bovis Tokyo 172 strain. No systemic symptoms were reported and on examination, no lymphadenitis was present. A wait-and-see treatment approach was adopted, the infant was discharged home, and a local health care worker documented the spontaneous resolution of the lesion and the natural course of healing (Fig. 1b-d) .
BCG vaccines have been used for nearly a century, are considered safe and remain recommended by a majority of countries [1] . Approximately 1-10% experience adverse reactions, of which most are localised (i.e. abscess, lymphadenitis); systemic adverse reactions (e.g. osteomyelitis, BCG disease) are rarely observed [2] . Adapting a conservative wait and see approach for localized BCG injection site reactions as well as non-suppurative lymphadenitis, leads to a self-limiting, spontaneous resolution of symptoms in the majority of cases.
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